Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Salivary Gland Neoplasms 1Bulbo-Spinal Atrophy, X-Linked 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

Docetaxel 3regorafenib 2Doxorubicin 2trifluridine tipiracil drug combination 1pegfilgrastim 1enzalutamide 1darolutamide 1bicalutamide 1apalutamide 1abiraterone 1Triptorelin Pamoate 1Trifluridine 1Surgical Procedures, Operative 1Pancreaticoduodenectomy 1Paclitaxel 1Nivolumab 1Irinotecan 1Cyclophosphamide 1Cisplatin 1CP protocol 1Bevacizumab 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Adenocarcinoma × CP protocol × Clear all
NCT01969578 2024-11-05

Androgen Deprivation Therapy in Advanced Salivary Gland Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
149 enrolled
Head & Neck

Adenocarcinoma, Salivary Gland Neoplasms, Bulbo-Spinal Atrophy, X-Linked

Data powered by HemOnc (CC BY 4.0) Colophon âš¡